Scotland

Joint venture snaps up Glasgow redevelopment site
Buccleuch Property and Sir Robert McAlpine Capital Ventures acquire 101 Centre Street for future mixed-use project

Scottish hotel group locks in £40m refinancing
HSBC facility to refinance Crerar’s 10 hotels in Scotland and in the Lake District
Latest Articles

Carlyle steels itself for £85m+ industrial sale
Savills is handling disposal of nine-asset portfolio

US private equity firm preps £160m retail park portfolio sale
Savills handling disposal of four-asset collection

LSH confirms acquisition of majority stake in Ryden
Scottish-headquartered business currently has more than 120 staff

Marriott to double Sheraton hotel portfolio across Europe
Company plans to reach more than 50 open properties over next two years
-
-
Life sciences
Golden Triangle take-up dips but Cambridge leads charge
-
Corporate
Avison Young’s Nick Walkley: “If you’re not in the big four, you can afford to take risks”
-
Retail
New asset manager takes the reins for one of UK’s biggest shopping malls
-
Opinion
How Heathrow expansion puts London’s industrial market in play
-
Hotels & Leisure
£400m boutique hotel business on the block
-
Residential
Green light for Criterion’s Camberwell Magistrates’ Court overhaul
-
Residential
GLA taps Vistry Group for Enfield scheme
-
Corporate
Knight Frank forms UK board and appoints adviser
-
People
Cushman’s APAC chief expands role to include EMEA
-
Office
South Bank office development pipeline biggest in London
-
Corporate
Patrizia’s UK heads depart
-
Corporate
LaSalle star Zerda to leave
-
London
Ares extends acquisitive run with £100m West End purchase
-
Corporate
Former KKR UK head scores with Neville and Fora
-
London
UK law firm shortlists trio for 300,000 sq ft London HQ hunt
-
Logistics
Chinese giant circles £650m airport portfolio
-
London
Former Oxford Street Debenhams offices fully let
-
London
UK law firm eyes 180,000 sq ft London HQ move
-
People
CBRE’s Ciaran Bird announces departure
-
Logistics
Greykite launches multi-let industrial platform with €1bn ambitions
-
Life sciences